Disease modifying agents in Parkinson's disease?

被引：0
|
作者：
Schapira, A. H. V. [1 ]
机构：
[1] Inst Neurol, London WC1N 3BG, England
来源：
JOURNAL OF THE NEUROLOGICAL SCIENCES | 2009年 / 285卷
关键词：
D O I：
10.1016/S0022-510X(09)70217-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S46 / S46
页数：1
相关论文
共 50 条
  • [31] Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson's disease
    Braithwaite, Steven P.
    Voronkov, Michael
    Stock, Jeffry B.
    Mouradian, M. Maral
    NEUROCHEMISTRY INTERNATIONAL, 2012, 61 (06) : 899 - 906
  • [32] Enhancement of glycolysis: A potential disease-modifying strategy for Parkinson's disease
    Morales-Briceno, Hugo
    Fung, Victor S. C.
    MOVEMENT DISORDERS, 2020, 35 (01) : 81 - 81
  • [33] FRAMEWORK FOR EARLY ECONOMIC ANALYSIS OF A DISEASE MODIFYING THERAPY FOR PARKINSON'S DISEASE
    Folse, H.
    Chandler, C.
    Gal, P.
    Chavan, A.
    Wang, Y.
    Ward, A.
    VALUE IN HEALTH, 2020, 23 : S275 - S275
  • [34] CDNF: An innovative actor in disease-modifying approaches for Parkinson's disease
    Tenenbaum, Liliane
    MOLECULAR THERAPY, 2021, 29 (09) : 2634 - 2636
  • [35] Phosphodiesterase 10 Inhibitors: New Disease Modifying Drugs for Parkinson's Disease?
    Garcia, A. M.
    Redondo, M.
    Martinez, A.
    Gil, C.
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (10) : 1171 - 1187
  • [36] Informing the design of disease modifying trials for Parkinson's disease - A Delphi study
    Zeissler, M.
    Windle, R.
    Raphael, K.
    Rafaloff, G.
    McFarthing, K.
    Matthews, H.
    Carroll, C.
    MOVEMENT DISORDERS, 2021, 36 : S200 - S200
  • [37] Translating scientific advances into disease-modifying therapies for Parkinson's Disease
    Cenci, M. Angela
    Olanow, C. Warren
    EXPERIMENTAL NEUROLOGY, 2017, 298 : 135 - 136
  • [38] Does Rasagiline Have a Disease-Modifying Effect on Parkinson’s Disease?
    Shyamal H. Mehta
    John C. Morgan
    Kapil D. Sethi
    Current Neurology and Neuroscience Reports, 2010, 10 (6) : 413 - 416
  • [39] α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
    Cole, Tracy A.
    Zhao, Hien
    Collier, Timothy J.
    Sandoval, Ivette
    Sortwell, Caryl E.
    Steece-Collier, Kathy
    Daley, Brian F.
    Booms, Alix
    Lipton, Jack
    Welch, Mackenzie
    Berman, Melissa
    Jandreski, Luke
    Graham, Danielle
    Weihofen, Andreas
    Celano, Stephanie
    Schulz, Emily
    Cole-Strauss, Allyson
    Luna, Esteban
    Quach, Duc
    Mohan, Apoorva
    Bennett, C. Frank
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    Luk, Kelvin C.
    Paumier, Katrina L.
    JCI INSIGHT, 2021, 6 (05)
  • [40] Peripheral Nerve Grafting as a Disease Modifying Cell Therapy for Parkinson's Disease
    El Seblani, Nader
    Welleford, Andrew
    Quintero, George
    Qian, April
    Pomerleau, Francois
    Huettl, Peter
    Van Horne, Craig
    Gerhardt, Greg
    NEUROLOGY, 2019, 92 (15)
12345